As of 2024-12-11, the EV/EBITDA ratio of XBiotech Inc (XBIT) is -0.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XBIT's latest enterprise value is 28.96 mil USD. XBIT's TTM EBITDA according to its financial statements is -34.47 mil USD. Dividing these 2 quantities gives us the above XBIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-12-06 | -0.64 |
| 2024-12-05 | -0.56 |
| 2024-12-04 | -0.73 |
| 2024-12-03 | -0.93 |
| 2024-12-02 | -1.30 |
| 2024-11-29 | -1.71 |
| 2024-11-27 | -1.48 |
| 2024-11-26 | -1.00 |
| 2024-11-25 | -1.04 |
| 2024-11-22 | -1.02 |
| 2024-11-21 | -0.83 |
| 2024-11-20 | -0.72 |
| 2024-11-19 | -0.88 |
| 2024-11-18 | -0.88 |
| 2024-11-15 | -0.87 |
| 2024-11-14 | -1.14 |
| 2024-11-13 | -1.26 |
| 2024-11-12 | -1.25 |
| 2024-11-11 | -1.43 |
| 2024-11-08 | -1.65 |
| 2024-11-07 | -1.49 |
| 2024-11-06 | -2.27 |
| 2024-11-05 | -1.57 |
| 2024-11-04 | -1.43 |
| 2024-11-01 | -1.48 |
| 2024-10-31 | -1.40 |
| 2024-10-30 | -1.51 |
| 2024-10-29 | -1.30 |
| 2024-10-28 | -1.80 |
| 2024-10-25 | -1.32 |
| 2024-10-24 | -1.38 |
| 2024-10-23 | -1.29 |
| 2024-10-22 | -1.62 |
| 2024-10-21 | -1.67 |
| 2024-10-18 | -1.65 |
| 2024-10-17 | -1.64 |
| 2024-10-16 | -1.80 |
| 2024-10-15 | -1.57 |
| 2024-10-14 | -1.79 |
| 2024-10-11 | -1.57 |
| 2024-10-10 | -1.14 |
| 2024-10-09 | -1.24 |
| 2024-10-08 | -1.06 |
| 2024-10-07 | -1.34 |
| 2024-10-04 | -1.59 |
| 2024-10-03 | -1.21 |
| 2024-10-02 | -1.61 |
| 2024-10-01 | -1.52 |
| 2024-09-30 | -1.81 |
| 2024-09-27 | -1.35 |